You just read:

Soligenix Announces Investor Webcast Event: Origins of Innate Defense Regulators and Review of the SGX942 Phase 2 Study Results in Oral Mucositis

News provided by

Soligenix, Inc.

Dec 08, 2016, 07:00 ET